In our patient cohort higher GAPDH abundance was correlated with lower MG-H1 modification frequency, less sLG accumulation in tumor as well as lower GLO1 but not GLO2 levels (Fig. 5D). The gene discussed is SIGLEC12; the disease is neoplasm.